Skip to main content
Log in

A step forward in the field of drug design: 1,5-benzothiazepines and their nucleosides

  • Published:
Research on Chemical Intermediates Aims and scope Submit manuscript

Abstract

(±)cis-2-(4-methoxyphenyl)-3-hydroxy/methoxy-6-methoxy/8-methoxy-2,3-dihydro-1,5-benzothiazepin-4-[5H/5-chloroacetyl/5-(4′-methylpiperazino-1′)acetyl]-ones and nucleosides viz; (±)cis-2-(4-methoxyphenyl)-3,6-dimethoxy-2,3-dihydro-1,5-benzothiazepin-4-[5-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)]-one and (±)cis-2-(4-methoxyphenyl)-3,8-dimethoxy-2,3-dihydro-1,5-benzothiazepin-4-[5-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)]-one have been synthesized by the condensation of substituted-2-aminobenzenethiols with methyl (±)trans-3-(4-methoxyphenyl)glycidate in xylene and by stirring the 3-methoxy derivative of 1,5-benzothiazepin-4(5H)-ones with sugar namely β-D-ribofuranosyl-1-acetate-2,3,5-tribenzoate at 155–160 °C in vacuo for 10 hours, respectively.

The synthesized compounds have been characterized by the elemental analyses and spectral data and screened for their antimicrobial activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E. Fischer and B. Helferich, Ber. Dtsch. Chem. Ges. 47, 210 (1914).

    Article  CAS  Google Scholar 

  2. I. Verheggen, A.V. Aerschot, S. Toppet, R. Snoeck, G. Janssen, J. Balzarini, E. de Clereq, and P. Herdewijn, J. Med. Chem. 3, 2033 (1993).

    Article  Google Scholar 

  3. I. Verheggen, A.V. Aerschot, L.V. Meervelt, J. Rozenski, L. Wiebe, R. Snoeck, G. Andrei, J. Balzarini, P. Claes, E. De Clereq, and P. Herdewijn, J. Med. Chem. 38, 826 (1995).

    Article  CAS  Google Scholar 

  4. V. Girijavallabhan, K. Ganguly, A.B. Cooper, R. Lovey, D. Loebenberg, D. Rane, J. Desai, R. Pike, and E. Jao. In: P.H. Bently and R. Ponsford (Eds.), Recent Advances in the Chemistry of Anti Infective Agents, The Royal Society of Chemistry, Cambridge, 1993, 192pp.

    Google Scholar 

  5. L. Agrofoglio, E. Suhas, A. Farese, R. Condom, S.R. Challand, R.A. Earl, and R. Guedj, Tetrahedron 50, 10611 (1994).

    Article  CAS  Google Scholar 

  6. M.J. Mulvihill and M.J. Miller, Tetrahedron 54, 6605 (1998).

    Article  CAS  Google Scholar 

  7. B. Doboszewski and P. Herdewijn, Tetrahedron 52, 165 (1996).

    Article  Google Scholar 

  8. J. Balzarini, G.J. Kang, M. Dalal, P. Herdewijn, E. De Clercq, S. Broder, and D.G. Johns, Mol. Pharmacol 32, 162 (1987).

    CAS  Google Scholar 

  9. A.M. Attia, G.H. Elgemeie, and L.A. Shahada, Tetrahedron 53(51), 17441 (1997).

    Article  CAS  Google Scholar 

  10. A. Odawara, Y. Sasaki, S. Murata, and H. Narita (Tanabe Seiyaku, Co., Ltd.) Eur. Pat. Appl. Ep 476, 854 (Cl. A 61K31/62), 25 Mar, 1992, JP Appl. 90/243, 728, 17 Sep 1990; 6 pp.; Chem. Abstr. 117, 11427 (1992).

  11. I.R. Buxton, A. Brown, H. Gitchlly, Leslic, T. Stewart, S. Malkowska, A. Therese, D.A. Prater, R.B. Miller (Euro Eoltique SA) Eur. Pat. Appl. EP 527, 638 (Cl. A61 K31/55), 17 Feb. 1993, G.B. Appl. EP 527, 638; Chem. Abstr. 118, 240944 (1993).

  12. De. Hendrickson, D.C. Dimitt, M.S. Williams, P.F. Skultely, M.J. Batezor (Marion Mersell Dow Inc.) Eur Pat. Appl. EP 514, 814 (Cl. A61 K31/55), 25 Nov. 1992, 25 Appl. 702, 567, 20 May 1991; 24 pp., Chem. Abstr. 118, 66884 (1993).

  13. Z.P. Harovitz, Psychosomatics 6, 281 (1965).

    Google Scholar 

  14. Z.P. Nygren, R. Larsson, and L. Slater, J. Cell Pharmacol. 2(4), 202 (1991).

    CAS  Google Scholar 

  15. K. Kikkawa, S. Murata, H. Iwasaki, W. Toriuni, K. Banno, and T. Naga, Arzneim Forsch. 42(6), 781 (1992).

    CAS  Google Scholar 

  16. A. Soriabine, J. Cardiovasc. Pharmacol. 9, 53 (1987).

    Article  Google Scholar 

  17. Harari, Yakuhin Kogyo Co. Ltd. Jpn. Kokai Tokkyo, Koho JP 58, 113, 186 (83, 113, 186) (Cl. CO7D279/16), 05 Jul. 1983, Appl. 81/210, 918 28 Dec. 1981; 6 pp.; Chem. Abstr. 99, 158489 (1983).

  18. A. Ooishi, M. Takeda, H. Nakajima, H. Nagao, Tanabe Seiyavu Co. Ltd., Jpn, Kokai Tokkyo Koho Jp 61, 267, 520 (86, 267, 520) (Cl-A61K31/55), 27 Nov. 1986, JP Appl. 84/253, 820, 29 Nov. 1984; 11 pp.; Chem. Abstr. 106, 149478 (1987).

  19. S. Murakami, T. Ikebe, I. Hakamada, O. Yaoka, Yoshitomi Pharmaceuticals Industries Ltd., Eur. Pat. Appl. EP 292, 923 (Cl. CO7K5/06), 30 Nov. 1987, JP Appl. 87/129, 414, 25 May 1987; 21 pp.; Chem. Abstr. 110, 212635 (1989).

  20. H. Iwasaki, K. Kitamura, and A. Ohtani, Tanabe Seiyaku Co. Ltd., Austrian AT 390,880 (Cl.A61K31/55), 10 Jul. 1990 Appl. 8712, 627, 18 Oct. 1987; 6 pp., Chem. Abstr. 115, 22228 (1991).

  21. N.K. Ahmed, Marion Merrel Dow, Inc., Eur. Pat. Appl. EP 430, 036 (Cl.A61K31/55), 05 Jun 1991, US App. 440, 121, 22 Nov. 1989; 7 pp.; Chem. Abstr. 116, 717 (1992).

    Google Scholar 

  22. A.W. Bauer, W.M.M. Kibby, J.C. Sherris, and M. Turk, Ann. J. Clin. Path 45, 493 (1966).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singh, G., Sharma, A.K., Kumar, N. et al. A step forward in the field of drug design: 1,5-benzothiazepines and their nucleosides. Res Chem Intermed 26, 445–453 (2000). https://doi.org/10.1163/156856700X00444

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1163/156856700X00444

Keywords

Navigation